Skip to main content
SpringerLink
Log in

European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000

  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1999. Eur J Nucl Med 2001; 28:BP2–BP8.

    Google Scholar 

  2. Silberstein EB, Ryan J and the Pharmacopoeia Committee of the Society of Nuclear Medicine. Prevalence of adverse reactions in nuclear medicine. J Nucl Med 1996; 37:185–192.

    CAS  PubMed  Google Scholar 

  3. Ellis B, Sampson CB. In: Sampson CB, ed. Textbook of radiopharmacy theory and practice. Gordon and Breach Science Publishers; 1999:83–104.

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, City Hospital N.H.S. Trust, Dudley Rood, Birmingham, B18 7QH, UK

    S.R. Hesslewood

Authors
  1. S.R. Hesslewood
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hesslewood, S. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000. Eur J Nucl Med 29, BP13–BP19 (2002). https://doi.org/10.1007/s00259-002-0771-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-002-0771-z

Keywords

Search

Navigation